Ukrainian Journal of Veterinary Sciences

Nutritional effects on mineral metabolism in cats with chronic kidney disease

Mykhailo Umanets, Valerii Tsvilikhovskyi
Download article
Abstract

The relevance of this study arises from the high prevalence of mineral metabolism disorders in cats with chronic kidney disease (CKD), which are accompanied by the development of hypercalcaemia and hyperphosphataemia and have a significant impact on prognosis and quality of life. Accordingly, the aim of the study was to assess the effect of different dietary calcium-to-phosphorus ratios on calcium-phosphorus homeostasis and the overall condition of cats with stage II CKD. The principal research method involved a comparative evaluation of clinical and biochemical parameters in animals depending on diet type, which enabled a comprehensive assessment of mineral metabolism changes. The study included fourteen cats divided into two groups. Group 1 animals received feed with a higher calcium-to-phosphorus ratio (1.71) and restricted phosphorus content, whereas group 2 cats were fed a diet with a moderate calcium-to-phosphorus ratio (1.33). Over a six-month period, blood biochemical parameters were monitored, including total and ionised calcium, phosphorus, creatinine, urea, and symmetric dimethylarginine concentrations. In addition, the cats’ clinical condition, body weight, muscle condition, body condition score, and arterial blood pressure were assessed, all of which remained stable in both experimental groups. It was found that cats in group 1 showed an increase in calcium levels, while cats in group 2 developed ionised hypercalcaemia. In group 2 cats, calcium levels remained stable without signs of hyperphosphataemia. Azotaemic markers did not differ significantly between the groups. Based on the obtained results, it was established that excessive phosphorus restriction leading to a high calcium-to-phosphorus ratio did not provide additional benefits in controlling phosphataemia but increased the risk of calcium metabolism disturbances. The material of this article holds practical value for veterinary clinicians, as it experimentally confirms the advisability of using diets with a moderate calcium-to-phosphorus ratio at early stages of chronic kidney disease in cats

Keywords

dietary effect; metabolic disorders; secondary hyperparathyroidism; phosphate binders; calcium homeostasis; nephrocalcinosis; renal diet

Suggested citation
Umanets, M., & Tsvilikhovskyi, V. (2025). Nutritional effects on mineral metabolism in cats with chronic kidney disease. Ukrainian Journal of Veterinary Sciences, 16(3), 63-77. https://doi.org/10.31548/veterinary3.2025.63
References

[1] AAFPCat friendly practice print (2023). Retrieved from https://www.scribd.com/document/859637023/AAFPCatFriendlyPracticePrint2023.

[2] Bjornvad, C.R., Nielsen, D.H., Armstrong, P.J., McEvoy, F.J., Hoelmkjaer, K.M., Jensen, K.S., Pedersen, G.F., & Kristensen, A.T. (2011). Evaluation of a nine-point body condition scoring system in physically inactive pet cats. American Journal of Veterinary Research, 72(4), 433-437. doi: 10.2460/ajvr.72.4.433.

[3] Directive of the European Parliament and of the Council No. 2010/63/EU “On the Protection of Animals Used for Scientific Purposes”. (2010, September). Retrieved from http://data.europa.eu/eli/dir/2010/63/oj.

[4] Ehrlich, M.R., Rudinsky, A.J., Chew, D.J., & Parker, V.J. (2024). Ionized hypercalcemia can resolve with nutritional modification in cats with idiopathic hypercalcemia or chronic kidney disease. Journal of Feline Medicine and Surgery, 26(2). doi: 10.1177/1098612X241229811.

[5] European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes. (1986, March). Retrieved from https://rm.coe.int/168007a67b.

[6] FEDIAF. (2024). Nutritional guidelines for complete and complementary pet food for cats and dogs. Retrieved from https://europeanpetfood.org/wp-content/uploads/2024/09/FEDIAF-Nutritional-Guidelines_2024.pdf.

[7] Fidalgo, M.A., Leal, R.O., & Duarte-Correia, J.H. (2022). Urinary protein/creatinine ratio in feline medicine: reasons to perform it and its role in clinical practice – a retrospective study. Animals, 12(12), article number 1575. doi: 10.3390/ani12121575.

[8] Geddes, R.F., van den Broek, D.H.N., Chang, Y.-M., Biourge, V., Elliott, J., & Jepson, R.E. (2021). The effect of attenuating dietary phosphate restriction on blood ionized calcium concentrations in cats with chronic kidney disease and ionized hypercalcemia. Journal of Veterinary Internal Medicine, 35(2), 997-1007. doi: 10.1111/jvim.16050.

[9] Hahn, L., & Callaband, C. (2022). Review of chronic kidney disease and comparison between humans, dogs, and cats. Journal of Student Research, 11(3). doi: 10.47611/jsrhs.v11i3.2999.

[10] Hokamp, J.A., & Nabity, M.B. (2016). Renal biomarkers in domestic species. Veterinary Clinical Pathology, 45(1), 28-56. doi: 10.1111/vcp.12333.

[11] International Renal Interest Society (IRIS). (2023). Treatment Recommendations for CKD in Cats. Retrieved from https://static1.squarespace.com/static/666b9ecb4064a156963b4162/t/66a6dc1dbfaa20426da8e99b/1722211357641/IRIS_CAT_Treatment_Recommendations_2023.pdf.

[12] Josera. (2024). Josera senior cat food: Product datasheet. Retrieved from https://www.josera.de/media/datatransfer/import/product/images/Datenblatt_Katze_Josera_GER_Senior.pdf.

[13] Krofič Žel, M., Tavčar Kalcher, G., Vovk, T., Žegura, B., Lusa, L., Tozon, N., & Nemec Svete, A. (2024). Supplementation of vitamin E as an addition to a commercial renal diet does not prolong survival of cats with chronic kidney disease. BMC Veterinary Research, 20, article number 308. doi: 10.1186/s12917-024-04176-8.

[14] Laflamme, D.P. (1997). Development and validation of a body condition score system for cats: A clinical tool. Feline Practice, 25(5-6), 13-18.

[15] Law of Ukraine No. 3447-IV “On the Protection of Animals from Cruelty”. (2006, February). Retrieved from https://zakon.rada.gov.ua/laws/show/3447-15#Text.

[16] Lin, J., Lin, L., Chen, S., Yu, L., Chen, S., & Xia, Z. (2021). Serum fibroblast growth factor-23 (FGF-23): Associations with hyperphosphatemia and clinical staging of feline chronic kidney disease. Journal of Veterinary Diagnostic Investigation, 33(2), 288-293. doi: 10.1177/1040638720985563.

[17] Machado, D.P., Ruberti, B., Teixeira, F.A., Vendramini, T.H.A., Pfrimer, K., Chacar, F.C., Balieiro, J.C.C., Pontieri, C.F.F., & Brunetto, M.A. (2022). Body composition of healthy cats and cats with chronic kidney disease fed on a dry diet low in phosphorus with maintenance protein. Toxins, 14(12), article number 865. doi: 10.3390/toxins14120865.

[18] Maniaki, E., Pineda, C., Hibbert, A., & Finch, N. (2024). Exploring the relationship between calcitonin, ionized calcium, and bone turnover in cats with and without naturally occurring hypercalcemia. Frontiers in Veterinary Science, 11, article number 1399942. doi: 10.3389/fvets.2024.1399942.

'[19] Michel, K.E., Anderson, W., Cupp, C., & Laflamme, D.P. (2011). Correlation of a feline muscle mass score with body composition determined by dual-energy X-ray absorptiometry. British Journal of Nutrition, 106(1), S57-S59. doi: 10.1017/S000711451100050X.

[20] Nestlé Purina. (2024). Purina Pro Plan veterinary diets. Retrieved from https://www.purina.ua/sites/default/files/2024-05/2024-04-12__Purina_Guide_A5.pdf.

[21] Parker, V.J. (2021). Nutritional management for dogs and cats with chronic kidney disease. Veterinary Clinics of North America: Small Animal Practice, 51(3), 685-710. doi: 10.1016/j.cvsm.2021.01.007.

[22] Pedrinelli, V., Lima, D.M., Duarte, C.N., Teixeira, F.A., Porsani, M., Zarif, C., Amaral, A.R., Vendramini, T., Kogika, M.M., & Brunetto, M.A. (2020). Nutritional and laboratory parameters affect the survival of dogs with chronic kidney disease. PLOS One, 15(6), article number e0234712. doi: 10.1371/journal.pone.0234712.

[23] Seiler, S., Heine, G.H., & Fliser, D. (2009). Clinical relevance of FGF-23 in chronic kidney disease. Kidney International. Supplement, 114, S34-S42. doi: 10.1038/ki.2009.405.

[24] Stockman, J. (2024). Dietary phosphorus and renal disease in cats: Where are we? Journal of Feline Medicine and Surgery, 26(10). doi: 10.1177/1098612X241283355.

[25] Tang, P.-K., Geddes, R.F., Chang, Y.-M., Jepson, R.E., Bijsmans, E., & Elliott, J. (2021). A feline-focused review of chronic kidney disease-mineral and bone disorders. Part 2: Pathophysiology of calcium disorders and extraosseous calcification. The Veterinary Journal, 275, article number 105718. doi: 10.1016/j.tvjl.2021.105718.

[26] Tang, P.-K., van den Broek, D.H.N., Jepson, R.E., Geddes, R.F., Chang, Y.-M., Lötter, N., Moniot, D., Biourge, V., & Elliott, J. (2024). Dietary magnesium supplementation in cats with chronic kidney disease: A prospective double-blind randomized controlled trial. Journal of Veterinary Internal Medicine, 38(4), 2181-2195. doi: 10.1111/jvim.17134.

[27] The ARRIVE guidelines 2.0. (n.d.). Retrieved from https://arriveguidelines.org/arrive-guidelines.

[28] WSAVA. (2013). Muscle condition score chart for cats. Retrieved from https://wsava.org/wp-content/uploads/2020/01/Muscle-Condition-Score-Chart-for-Cats.pdf.

[29] Zhang, W., Lou, B., Peng, Y., Wu, F., Zhang, D., & Wang, Q. (2024). High dietary calcium to phosphorus ratio is associated with high prevalence of kidney stone. Medicine, 103(50), article number e40778. doi: 10.1097/MD.0000000000040778.